PRNewsWire
04 Aug 2026, 10:45 UTC · 6w ago
Verdict
Headline takes no side. We score SOPH +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
SOPHiA GENETICS signed two companion diagnostic programs with AstraZeneca, marking the first such programs in the company's history.
More positive than 98% of claims this week
The company reported 27% year-over-year revenue growth and a 27% improvement in adjusted EBITDA loss for Q2 2026.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 91% of claims this week
SOPHiA GENETICS raised $57.5 million through an oversubscribed public offering in the second quarter.
So whatThe successful capital raise strengthens the balance sheet and provides the necessary runway to execute long-term growth strategies.
More positive than 76% of claims this week
The company saw significant volume growth in the U.S. (60%) and Liquid Biopsy (70%) during the quarter.
More positive than 64% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company reported 27% year-over-year revenue growth, reduced EBITDA loss, and secured two new companion diagnostic programs.
More positive than 50% of ticker scores this week
The company entered into two new companion diagnostic programs with SOPHiA GENETICS, indicating business expansion.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Fox Business
1d ago
+43.9%
Price agrees with the score
$8.19 vs $5.69 close before publication (Aug 3) · not market-adjusted
SOPH chart →
